Home
SXTP
SXTP News

Latest 60 Degrees Pharmaceuticals Inc. (SXTP) News on July 27, 2024

60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support

GlobeNewswire

a day ago

60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support

60 Degrees Pharmaceuticals enters deals for babesiosis treatment trial

Clinical Trials Arena

5 days ago

60 Degrees Pharmaceuticals enters deals for babesiosis treatment trial

MT Newswires

7 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires

7 days ago

Sector Update: Health Care

MT Newswires

7 days ago

Top Midday Gainers

MT Newswires

7 days ago

60 Degrees Signs Testing Deals for Potential Babesiosis Drug -- Shares Rise Pre-Bell

60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

GlobeNewswire

8 days ago

60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment

GlobeNewswire

18 days ago

60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment

First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind

GlobeNewswire

a month ago

First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind

60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis

GlobeNewswire

2 months ago

60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis

Business Wire

2 months ago

Net Asset Value(s)

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Newsfile

2 months ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Dstny honored with 'Employee Wellbeing Award'

PR Newswire

2 months ago

Dstny honored with 'Employee Wellbeing Award'

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Business Wire

2 months ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

GlobeNewswire

2 months ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Business Wire

2 months ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

PR Newswire

2 months ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

GlobeNewswire

2 months ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

Simply Wall St.

2 months ago

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

Better AI Stock: Palantir vs. Snowflake

Motley Fool

2 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

2 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

Simply Wall St.

2 months ago

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

2 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

2 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind

GlobeNewswire

2 months ago

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind

60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study

GlobeNewswire

2 months ago

60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results

GlobeNewswire

2 months ago

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results

60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases

GlobeNewswire

3 months ago

60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

GlobeNewswire

3 months ago

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

GlobeNewswire

4 months ago

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

60 Degrees Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

60 Degrees Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024

GlobeNewswire

4 months ago

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris

GlobeNewswire

5 months ago

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

GlobeNewswire

6 months ago

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 02/05/2024

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

PR Newswire

6 months ago

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

GlobeNewswire

6 months ago

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

PR Newswire

6 months ago

WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering

GlobeNewswire

6 months ago

60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering

60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting

GlobeNewswire

6 months ago

60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting

GlobeNewswire

6 months ago

Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination

Banzai Executes LOI to Acquire Cliently, An AI-Driven Sales Engagement Platform

GlobeNewswire

6 months ago

Banzai Executes LOI to Acquire Cliently, An AI-Driven Sales Engagement Platform

60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

6 months ago

60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements

STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?

Simply Wall St.

7 months ago

STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?

Trinity Place Holdings Inc. Enters Into Recapitalization Transactions

Business Wire

7 months ago

Trinity Place Holdings Inc. Enters Into Recapitalization Transactions

U.S. Energy Corp. Announces Completion of Asset Divestitures and Provides Liquidity Update

GlobeNewswire

7 months ago

U.S. Energy Corp. Announces Completion of Asset Divestitures and Provides Liquidity Update

Banzai Unveils 2024 Webinar Insights Guide: The Must-Have Resource for Marketers Seeking Successful Webinar Strategies

GlobeNewswire

7 months ago

Banzai Unveils 2024 Webinar Insights Guide: The Must-Have Resource for Marketers Seeking Successful Webinar Strategies

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

NewMediaWire

7 months ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference

GlobeNewswire

7 months ago

STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference

ACCESSWIRE

7 months ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

GSI Technology Receives Award from U.S. Air Force Research Laboratory to Demonstrate High-Data Computation Use Cases Leveraging Its Next-Generation APU

GlobeNewswire

7 months ago

GSI Technology Receives Award from U.S. Air Force Research Laboratory to Demonstrate High-Data Computation Use Cases Leveraging Its Next-Generation APU

60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024

GlobeNewswire

7 months ago

60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024

Euro Tech Holdings Company Limited Reports Interim Results For The Six Months Ended June 30, 2023

PR Newswire

7 months ago

Euro Tech Holdings Company Limited Reports Interim Results For The Six Months Ended June 30, 2023

Complete Solaria Appoints Solar Industry Veteran and Growth Expert Chris Lundell as its New CEO

GlobeNewswire

8 months ago

Complete Solaria Appoints Solar Industry Veteran and Growth Expert Chris Lundell as its New CEO

10 Best Debt Free Penny Stocks To Buy Now

Insider Monkey

8 months ago

10 Best Debt Free Penny Stocks To Buy Now

Ondas Holdings’ American Robotics and MassDOT Aeronautics to Start a Pilot Program of the Optimus-1EX: the First FAA-Certified Data Capturing Drone System in the U.S.

ACCESSWIRE

8 months ago

Ondas Holdings’ American Robotics and MassDOT Aeronautics to Start a Pilot Program of the Optimus-1EX: the First FAA-Certified Data Capturing Drone System in the U.S.

Arbe Wins Self-Driving Industry 2023 Award from Cars of the Future

PR Newswire

8 months ago

Arbe Wins Self-Driving Industry 2023 Award from Cars of the Future

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript

Insider Monkey

8 months ago

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript

60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease

GlobeNewswire

8 months ago

60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease

LifeWallet Announces Third Quarter 2023 Financial Results

GlobeNewswire

8 months ago

LifeWallet Announces Third Quarter 2023 Financial Results

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Associated Press Finance

8 months ago

Acorda: Q3 Earnings Snapshot

Acorda Therapeutics Reports Third Quarter 2023 Financial Results

Business Wire

8 months ago

Acorda Therapeutics Reports Third Quarter 2023 Financial Results

FreightCar America, Inc. (NASDAQ:RAIL) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

FreightCar America, Inc. (NASDAQ:RAIL) Q3 2023 Earnings Call Transcript

Hennessy Advisors (NASDAQ:HNNA) Is Paying Out A Dividend Of $0.1375

Simply Wall St.

9 months ago

Hennessy Advisors (NASDAQ:HNNA) Is Paying Out A Dividend Of $0.1375

LifeWallet Announces It Is In Compliance with All Applicable Nasdaq Listing Standards

GlobeNewswire

9 months ago

LifeWallet Announces It Is In Compliance with All Applicable Nasdaq Listing Standards

Share on Social Networks: